Patient_Reported_Outcome_Measures_in_Rheumatic_Diseases

449

DFI , 127
HAQ-DI , 135
Health Assessment Questionnaire , 127
radiographic damage , 126
SF-36 , 136
spinal mobility measures , 126
classifi cation , 122
PsA
clinical outcomes , 129
DLQI , 133
domains , 128 , 129
HAQ-DI , 135
impact of , 128
pain , 134
PGA , 133–134
PsAID , 132–133
PsAQoL , 130–132
qualitative methods , 130 , 131
SF-36 , 136
Symptom Burden Index (SBI) , 294
Synovial hypertrophy , 420
Systemic lupus erythematosus (SLE) , 64
characteristics , 152–157
conceptual model , 150 , 151
emotional well-being , 155–156
fatigue , 150–153
HRQoL
generic assessment , 157–158
SLE , 158–159
pain , 153–155
Systemic sclerosis (SSc)
chronological list , 290–292
diffuse cutaneous , 287
digital ulcers , 299
dyspnea , 298
EuroQol-5D , 293
FACIT , 299–300
fatigue , 298
gastrointestinal disease , 295–296

global assessments , 293–294

hand function , 296–297

HAQ , 290–293

instruments , 290

interstitial lung disease , 288

limited cutaneous , 287

mouth disability , 297

organ-based complications , 289

PAH , 299

pain , 297

PROMIS , 299–300

Raynaud’s condition score , 299

SBI , 294

Short-Form Health Survey , 294

UKFS , 295

visual depiction , 288

T

Tenosynovitis , 421

Transition Dyspnea Index (TDI) , 298

U

UK Scleroderma Functional

Score (UKFS) , 295

V

Vision-targeted health-related quality of life

(VT-HRQ) instruments , 316

Visual analogue scale (VAS) , 358

Visual analogue scale FIQ (VASFIQ) , 183

W

Western Ontario and McMaster Universities

Osteoarthritis Index (WOMAC) ,

254–255

Index